BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 19, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Nov. 23, 2009
View Archived Issues
SPAs on the Rise for Many, Despite Setbacks for a Few
Twice this month, biotechs that achieved their primary endpoints in a pivotal trial conducted under a special protocol assessment (SPA) found their drugs turned down by the FDA.
Read More
Of Vivus and Viagra: Could Patent Expiry Rattle ED Bid?
Read More
Money Raised Year to Date
Read More
Money Raised By Biotech in 2009
Read More
Week in Review
Read More
Word on the Street
Read More
Biotechnology Company Deals With Other Biotechnology Companies: October 1 - November 19, 2009
Read More
Manufacturing, Marketing And Distribution Agreements Between Biotech Companies: October 1 - November 19, 2009
Read More
Biotech - Biotech Collaborations: Modified Agreements: October 1 - November 19, 2009
Read More
Stock Gainers and Losers For The Week
Read More
BioWorld Stock Report For Public Biotechnology Companies
Read More